This panel series, featuring renowned experts Kapil Arya, MD; Juan Francisco Vazquez Costa, MD, PhD; and Mary Schroth, offers neurologists an in-depth look into the latest advancements in the diagnosis of spinal muscular atrophy (SMA). Across six comprehensive segments, these leading clinicians and researchers explore the evolving best practices, emerging evidence, and critical updates that impact both clinical care and patient outcomes. The series covers essential topics, including newborn screening protocols, the role of early diagnosis, adult-onset 5q SMA, and the importance of timely treatment access. Tailored for the medical community, this series provides key insights into the future of SMA diagnosis and management.
EP. 1: Key Updates in SMA Diagnosis: What Clinicians Should Know
October 9th 2024In this episode, our panel of experts delves into the latest updates on spinal muscular atrophy diagnosis, focusing on the critical role of newborn screening, early intervention, and evolving classification methods for improved patient outcomes.
EP. 3: Newborn Screening for SMA: Clinical Recommendations and Considerations
October 11th 2024In this discussion, experts provide key considerations in the process of newborn screening for SMA, noting the need for developing local protocols and understanding the limitations of screening infants early in life.